Activation of AMP-activated protein kinase decreases receptor activator of NF-κB ligand expression and increases sclerostin expression by inhibiting the mevalonate pathway in osteocytic MLO-Y4 cells

These findings indicated that AMPK regulated RANKL and sclerostin expression through the mevalonate pathway in osteocytes.